Home Cart 0 Sign in  
X

[ CAS No. 311-46-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 311-46-6
Chemical Structure| 311-46-6
Chemical Structure| 311-46-6
Structure of 311-46-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 311-46-6 ]

Related Doc. of [ 311-46-6 ]

Alternatived Products of [ 311-46-6 ]

Product Details of [ 311-46-6 ]

CAS No. :311-46-6 MDL No. :MFCD00015677
Formula : C6H13O5P Boiling Point : -
Linear Structure Formula :- InChI Key :HUNISAHOCCASGM-UHFFFAOYSA-N
M.W : 196.14 Pubchem ID :67555
Synonyms :

Calculated chemistry of [ 311-46-6 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.07
TPSA : 71.64 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.67 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.01
Log Po/w (XLOGP3) : -0.24
Log Po/w (WLOGP) : 1.04
Log Po/w (MLOGP) : -0.18
Log Po/w (SILICOS-IT) : -0.23
Consensus Log Po/w : 0.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.51
Solubility : 60.8 mg/ml ; 0.31 mol/l
Class : Very soluble
Log S (Ali) : -0.81
Solubility : 30.6 mg/ml ; 0.156 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.04
Solubility : 17.7 mg/ml ; 0.0904 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.35

Safety of [ 311-46-6 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P362+P364-P403+P233-P501 UN#:3082
Hazard Statements:H302-H315-H318-H335-H411 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 311-46-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 311-46-6 ]
  • Downstream synthetic route of [ 311-46-6 ]

[ 311-46-6 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 4746-97-8 ]
  • [ 311-46-6 ]
  • [ 51656-91-8 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 0 - 20℃; for 1 h;
Stage #2: at 0 - 20℃; for 16 h;
Triethylphosphono acetate (6lmL, 0.3Omol) was added to a suspention KOBu-t(33g, 0.3Omol) in DMF (200mL) at 0 00, stirred for lh at RT. A solution of 1,4- dioxaspiro[4.5]decan-8-one (40g, 0.25mo1) in DMF (200mL) was added at 0 C and the whole then stirred for 16h at RT. The reaction mixture was quenched with sat NH4CI solutionand extracted with ethyl acetate (2X500mL). The combined organic layer was washed with water, brine,dried over Na2SO4 and distilled under reduced pressure to afford crude, which was purified by column chromatography (silica gel; 60-l20mesh); the product eluted with 10- 15percentethyl acetate in hexane to yield 50.Og (86percent) of Ethyl-2-(1,4-dioxaspiro-[4.5]-decan-8- ylidene)-acetate as liquid.
Reference: [1] Patent: WO2016/8582, 2016, A1, . Location in patent: Page/Page column 65
[2] Journal of the American Chemical Society, 1991, vol. 113, # 21, p. 8016 - 8024
[3] Tetrahedron Letters, 1993, vol. 34, # 22, p. 3505 - 3508
  • 2
  • [ 105-39-5 ]
  • [ 121-45-9 ]
  • [ 311-46-6 ]
YieldReaction ConditionsOperation in experiment
84% at 150℃; for 0.166667 h; Large scale The dry and clean 500mL coil was heated to 150 degree celcius , take the compound 1 (standard atmospheric pressure boiling point of 142 ~145 ° C) 1000 g (0.7 eq. 8.16 mol) was placed in a shot bottle A,Add 4000g toluene dilution, take trimethyl phosphite (standard Atmospheric pressure at the boiling point of 112 ° C) 1417g (1.0eq.11.42mol) placed in the bottle B, adding 3583g toluene diluted until The coil was started at a stable temperature and pump A (compound 1 in toluene): 25.0 g / min, pump B (trimethyl phosphite):25.0 g / min. Residence time 10min, the reaction pressure is 0.5 ~ 2.0Mpa. The discharge port is directly connected to the thin film evaporation device, control The pressure of 4 ~ 10 × 102Pa, temperature 95 ~ 105 , the final product Compound 3 (boiling point 110 ~ 112 , 466Pa) 1344 g, yield 84percent.
Reference: [1] Patent: CN107163079, 2017, A, . Location in patent: Paragraph 0068; 0069; 0070; 0071
[2] Bulletin de la Societe Chimique de France, 1965, p. 1925 - 1930
[3] Tetrahedron Letters, 1999, vol. 40, # 8, p. 1455 - 1458
  • 3
  • [ 623-73-4 ]
  • [ 121-45-9 ]
  • [ 311-46-6 ]
Reference: [1] Tetrahedron, 2008, vol. 64, # 32, p. 7555 - 7560
[2] Journal of the American Chemical Society, 2003, vol. 125, # 20, p. 6034 - 6035
  • 4
  • [ 67-56-1 ]
  • [ 16139-79-0 ]
  • [ 311-46-6 ]
  • [ 625396-71-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2005, vol. 53, # 1, p. 131 - 134
  • 5
  • [ 67-56-1 ]
  • [ 16139-79-0 ]
  • [ 311-46-6 ]
  • [ 5927-18-4 ]
  • [ 625396-69-2 ]
  • [ 625396-71-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2005, vol. 53, # 1, p. 131 - 134
  • 6
  • [ 67-56-1 ]
  • [ 42451-44-5 ]
  • [ 311-46-6 ]
Reference: [1] J. Gen. Chem. USSR (Engl. Transl.), 1976, vol. 46, p. 529 - 534[2] Zhurnal Obshchei Khimii, 1976, vol. 46, # 3, p. 534 - 540
  • 7
  • [ 105-36-2 ]
  • [ 121-45-9 ]
  • [ 311-46-6 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1964, vol. 259, p. 2244 - 2247
  • 8
  • [ 67-56-1 ]
  • [ 16139-79-0 ]
  • [ 311-46-6 ]
  • [ 5927-18-4 ]
  • [ 625396-69-2 ]
  • [ 625396-71-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2005, vol. 53, # 1, p. 131 - 134
  • 9
  • [ 311-46-6 ]
  • [ 79099-07-3 ]
  • [ 135716-08-4 ]
Reference: [1] Patent: US2003/229074, 2003, A1, . Location in patent: Page 20
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 19, p. 5652 - 5656
Same Skeleton Products
Historical Records